Angiopoietin-like proteins and lipid metabolism

Cellular Lipid Metabolism

Volumn , Issue , 2009, Pages 237-249

  Kersten, Sander ^a,b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957598083     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-00300-4_9     Document Type: Chapter

References (58)

1. Akiyama TE, Lambert G, Nicol CJ, Matsusue K, Peters JM, Brewer HB Jr, Gonzalez FJ (2004) Peroxisome proliferator-Activated receptor beta/delta regulates very low density lipoprotein production and catabolism in mice on a Western Diet. J Biol Chem 279 : 20874-20881
2. Ando Y, Shimizugawa T, Takeshita S, Ono M, Shimamura M, Koishi R, Furukawa H (2003) A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice. J Lipid Res 4 4: 1 216- 1 223
3. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101 : 15718-15723
4. Belanger AJ, Lu H, Date T, Liu LX, Vincent KA, Akita GY, Cheng SH, Gregory RJ, Jiang C (2002) Hypoxia up-regulates expression of peroxisome proliferator-Activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: Role of hypoxia inducible factor 1alpha. J Mol Cell Cardiol 34 : 765-774
5. Bunger M, van Den Bosch HM, van Der Meijde J, Kersten S, Hooiveld GJ, Muller M (2007) Genomewide analysis of PPARalpha activation in murine small intestine. Physiol Genomics 30 : 192-204
6. Cazes A, Galaup A, Chomel C, Bignon M, Brechot N, Le Jan S, Weber H, Corvol P, Muller L, Germain S, Monnot C (2006) Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res 99 : 1207-1215
7. Conklin D, Gilbertson D, Taft DW, Maurer MF, Whitmore TE, Smith DL, Walker KM, Chen LH, Wattler S, Nehls M, Lewis KB (1999) Identification of a mammalian angiopoietin-related protein expressed specifically in liver. Genomics 62 : 477-482
8. Desai U, Lee EC, Chung K, Gao C, Gay J, Key B, Hansen G, Machajewski D, Platt KA, Sands AT, et al (2007) Lipid-lowering effects of anti-Angiopoietin- like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc Natl Acad Sci USA 104 : 11766-11771
9. Dutton S, Trayhurn P (2008) Regulation of angiopoietin-like protein 4/fasting-induced adipose factor (Angptl4/FIAF) expression in mouse white adipose tissue and 3T3-L1 adipocytes. Br J Nutr 100 : 18-26
10. Fugier C, Tousaint JJ, Prieur X, Plateroti M, Samarut J, Delerive P (2006) The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone. J Biol Chem 281 : 11553-11559
11. Fujimoto K, Koishi R, Shimizugawa T, Ando Y (2006) Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp Anim 55 : 27-34
12. Galaup A, Cazes A, Le Jan S, Philippe J, Connault E, Le Coz E, Mekid H, Mir LM, Opolon P, Corvol P, et al (2006) Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA 103 : 18721-18726
13. Ge H, Yang G, Huang L, Motola DL, Pourbahrami T, Li C (2004a) Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J Biol Chem 279 : 2038-2045
14. Ge H, Yang G, Yu X, Pourbahrami T, Li C (2004b) Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J Lipid Res 45 : 2071-2079
15. Ge H, Cha JY, Gopal H, Harp C, Yu X, Repa JJ, Li C (2005) Differential regulation and properties of angiopoietin-like proteins 3 and 4. J Lipid Res 46 : 1484-1490
16. Gustavsson M, Mallard C, Vannucci SJ, Wilson MA, Johnston MV, Hagberg H (2007) Vascular response to hypoxic preconditioning in the immature brain. J Cereb Blood Flow Metab 27 : 928-938
17. Hatsuda S, Shoji T, Shinohara K, Kimoto E, Mori K, Fukumoto S, Koyama H, Emoto M, Nishizawa Y (2007) Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects. J Vasc Res 44 : 61-66
18. Hermann LM, Pinkerton M, Jennings K, Yang L, Grom A, Sowders D, Kersten S, Witte DP, Hirsch R, Thornton S (2005) Angiopoietin-like-4 is a potential angiogenic mediator in arthritis. Clin Immunol 115 : 93-101
19. Inaba T, Matsuda M, Shimamura M, Takei N, Terasaka N, Ando Y, Yasumo H, Koishi R, Makishima M, Shimomura I (2003) Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. JBiolChem 278 : 21344-21351
20. Inukai K, Nakashima Y, Watanabe M, Kurihara S, Awata T, Katagiri H, Oka Y, Katayama S (2004) ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states. Biochem Biophys Res Commun 317 : 1075-1079
21. Ito Y, Oike Y, Yasunaga K, Hamada K, Miyata K, Matsumoto S, Sugano S, Tanihara H, Masuho Y, Suda T (2003) Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res 63 : 6651-6657
22. Jin W, Wang X, Millar JS, Quertermous T, Rothblat GH, Glick JM, Rader DJ (2007) Hepatic proprotein convertases modulate HDL metabolism. Cell Metab 6 : 129-136
23. Josephs T, Waugh H, Kokay I, Grattan D, Thompson M (2007) Fasting-induced adipose factor identified as a key adipokine that is up-regulated in white adipose tissue during pregnancy and lactation in the rat. J Endocrinol 194 : 305-312
24. Kaplan R, Zhang T, Hernandez M, Gan FX, Wright SD, Waters MG, Cai TQ (2003) Regulation of the angiopoietin-like protein 3 gene by LXR. J Lipid Res 44 : 136-143
25. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, et al (2008) Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40 : 189-197
26. Kersten S, Mandard S, Tan NS, Escher P, Metzger D, Chambon P, Gonzalez FJ, Desvergne B, Wahli W (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-Activated receptor target gene. J Biol Chem 275 : 28488-28493
27. Kim I, Kim HG, Kim H, Kim HH, Park SK, Uhm CS, Lee ZH, Koh GY (2000) Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin- related protein that prevents endothelial-cell apoptosis. Biochem J 346 : 603-610
28. Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, Horikoshi H, Furukawa H (2002) Angptl3 regulates lipid metabolism in mice. Nat Genet 30 : 151-157
29. Koster A, Chao YB, Mosior M, Ford A, Gonzalez-DeWhitt PA, Hale JE, Li D, Qiu Y, Fraser CC, Yang DD, et al (2005) Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: Regulation of triglyceride metabolism. Endocrinology 146 : 4943-4950
30. Le Jan S, Amy C, Cazes A, Monnot C, Lamande N, Favier J, Philippe J, Sibony M, Gasc JM, Corvol P, Germain S (2003) Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. AmJPathol 162 : 1521-1528
31. Lichtenstein L, Berbee JF, van Dijk SJ, van Dijk KW, Bensadoun A, Kema IP, Voshol PJ, Muller M, Rensen PC, Kersten S (2007) Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- And HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol 27 : 2420-2427
32. Mandard S, Zandbergen F, Tan NS, Escher P, Patsouris D, Koenig W, Kleemann R, Bakker A, Veenman F, Wahli W, et al (2004) The direct peroxisome proliferator-Activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem 279 : 34411-34420
33. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M, Kersten S (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281 : 934-944
34. Matsusue K, Miyoshi A, Yamano S, Gonzalez FJ (2006) Ligand-Activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR. Mol Cell Endocrinol 256 : 23-33
35. Merkel M, Eckel RH, Goldberg IJ (2002) Lipoprotein lipase: Genetics, lipid uptake, and regulation. J Lipid Res 43 : 1997-2006
36. Ono M, Shimizugawa T, Shimamura M, Yoshida K, Noji-Sakikawa C, Ando Y, Koishi R, Furukawa H (2003) Protein region important for regulation of lipid metabolism in ANGPTL3: ANGPTL3 is cleaved and activated in vivo. J Biol Chem
37. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massague J (2008) TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133 : 66-77
38. Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs HH, Cohen JC (2007) Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 39 : 513-516
39. Ruge T, Svensson M, Eriksson JW, Olivecrona G (2005) Tissue-specific regulation of lipoprotein lipase in humans: Effects of fasting. Eur J Clin Invest 35 : 194-200
40. Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, Chang S, Lau P, Fowler AJ, Chuang G, Moser AH, et al (2004) Peroxisome proliferator-Activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 122 : 971-983
41. Schug TT, Berry DC, Shaw NS, Travis SN, Noy N (2007) Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129 : 723-733
42. Shimamura M, Matsuda M, Kobayashi S, Ando Y, Ono M, Koishi R, Furukawa H, Makishima M, Shimomura I (2003) Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res Commun 301 : 604-609
43. Shimamura M, Matsuda M, Ando Y, Koishi R, Yasumo H, Furukawa H, Shimomura I (2004) Leptin and insulin Down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor. Biochem Biophys Res Commun 322 : 1080-1085
44. Shimamura M, Matsuda M, Yasumo H, Okazaki M, Fujimoto K, Kono K, Shimizugawa T, Ando Y, Koishi R, Kohama T, et al (2007) Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol 27 : 366-372
45. Shimizugawa T, Ono M, Shimamura M, Yoshida K, Ando Y, Koishi R, Ueda K, Inaba T, Minekura H, Kohama T, Furukawa H (2002) ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem JID - 2985121R 277 : 33742-33748
46. Staiger H, Machicao F, Werner R, Guirguis A, Weisser M, Stefan N, Fritsche A, Haring HU (2008) Genetic variation within the ANGPTL4 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus. Metabolism 57 : 637-643
47. Stejskal D, Karpisek M, Humenanska V, Solichova P, Stejskal P (2007) Angiopoietin-like protein 3: Development, analytical characterization, and clinical testing of a new ELISA. Gen Physiol Biophys 26 : 230-233
48. Stejskal D, Karpisek M, Reutova H, Humenanska V, Petzel M, Kusnierova P, Vareka I, Varekova R, Stejskal P (2008) Angiopoietin-like protein 4: Development, analytical characterization, and clinical testing of a new ELISA. Gen Physiol Biophys 27 : 59-63
49. Sukonina V, Lookene A, Olivecrona T, Olivecrona G (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci USA 103 : 17450-17455
50. Wang B, Wood IS, Trayhurn P (2007) Dysregulation of the expression and secretion of inflammationrelated adipokines by hypoxia in human adipocytes. Pflugers Arch 455 : 479-492
51. Wiesner G, Morash BA, Ur E, Wilkinson M (2004) Food restriction regulates adipose-specific cytokines in pituitary gland but not in hypothalamus. J Endocrinol 180 : R1-R6
52. Wiesner G, Brown RE, Robertson GS, Imran SA, Ur E, Wilkinson M (2006) Increased expression of the adipokine genes resistin and fasting-induced adipose factor in hypoxic/ischaemic mouse brain. Neuroreport 17 : 1195-1198
53. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, et al (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40 : 161-169
54. Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RL, Xu JY, Chen B, Chow WS, Tso AW, Lam KS (2005) Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci USA 102 : 6086-6091
55. Yoon JC, Chickering TW, Rosen ED, Dussault B, Qin Y, Soukas A, Friedman JM, Holmes WE, Spiegelman BM (2000) Peroxisome proliferator-Activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol Cell Biol 20 : 5343-5349
56. Yoshida K, Shimizugawa T, Ono M, Furukawa H (2002) Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 43 : 1770-1772
57. Yu X, Burgess SC, Ge H, Wong KK, Nassem RH, Garry DJ, Sherry AD, Malloy CR, Berger JP, Li C (2005) Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc Natl Acad Sci USA 102 : 1767-1772
58. Zandbergen F, van Dijk S, Muller M, Kersten S (2006) Fasting-induced adipose factor/ Angiopoietin-like protein 4: A potential target for dyslipidemia. Future Lipidol 1 : 227-236